The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort
Open accessAbstract
85 Objectives: In clinical practice, current guidelines recommend FDG-PET/CT: 1) to characterize SPN in patients with low to moderate pretest probability of malignancy and 2) for staging patients in whom malignancy is strongly suspected or confirmed. The aim of this study was to assess the performance of FDG-PET/CT considering categorical and continuous FDG uptake, for both intra and extra-thoracic disease. We also evaluated the relationship between clinical, demographical or morphological variables with abnormal FDG activity. Methods: We retrospectively selected 225 consecutive patients (age:67±13 years), without cancer history investigated by FDG-PET/CT for characterization of SPN. According to clinical and instrumental pre-test probability of malignancy (Brock model), patients were stratified in low, intermediate and high malignancy risk categories. FDG uptake in SPN was assessed by a 4-point scoring system and by semi-quantitative analysis of the lung nodule (SUVmax) and in the blood pool (BP) and in the liver (L) (SUVmean). Histopathological and/or follow-up data were used as standard of reference. Diagnostic accuracy of FDG PET/CT in the characterization of SPN was assessed by standard methods. Cut-off values for continuous variables were calculated by ROC analysis. Logistic regression analysis was used to determine the predictors of abnormal FDG uptake. Results: Histology was available in 164 and follow-up data in 61 patients. SPN was malignant in 111 patients and benign in 114. In all 225 patients considering categorical data analysis (FDG uptake 蠅2 vs. <2), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of PET/CT for the characterization of SPN were 79%, 75%,75%, 79% and 77%, respectively. Sensitivity and PPV were higher in patients with intermediate and high-risk, while specificity and NPV were higher in low risk category. The cut-offs for better discriminating between benign and malignant lung nodules were 1.60 (81% for both sensitivity and specificity) for SUVmax/SUVmeanBP ratio and 1.21 (81% sensitivity and 80% specificity) for SUVmax/SUVmeanL ratio. In patients at intermediate and high risk of malignancy, by including the SUVmax/SUVmean BP ratio, the specificity shift from 71% to 80% and from 64% to 89%, respectively. In all 225 patients, SUVmax/SUVmeanBP and SUVmax/SUVmeanL ratios were significantly higher in patients with intra-thoracic lesions than without (t-Student test; both <0.05). Furthermore, at multivariate analysis, a high malignancy risk and a FDG uptake > 2 point score in the lung nodule were predictors of intra-thoracic pathological uptake (both p<0.05). Conclusion: FDG PET/CT by 4 point scale assessment has an acceptable performance in patients with SPN. Considering semi-quantitative continuous data (i.e SUVmax/SUVmeanBP ratio) the accuracy significantly improve, particularly in patients with intermediate and high risk of malignancy. Moreover, this ratio can be useful for the evaluation of disease spread in intra-thoracic site. Finally, stratification for risk category and FDG uptake in the lung nodules are predictors of intra-thoracic pathological sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
Cited by
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547
Self-citationNeuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
Metadata
- Authors
- Zaccai, J., Brayne, C., McKeith, I., Matthews, F., & Ince, P. G.
- Venue
- Neurology
- Published
- 2008-03-25
- Volume
- 70
- Issue
- 13
- Pages
- 1042-1048
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2163245612
- Cited by
- 244
- References
- 7
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort. https://app.cochat.ai/papers/10.1212/01.wnl.0000306697.48738.b6
- The paper
- Zaccai, J., Brayne, C., McKeith, I., Matthews, F., & Ince, P. G. (2008). Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort. Neurology. https://doi.org/10.1212/01.wnl.0000306697.48738.b6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.